cancer therapy

NYT weighs in on trend towards consolidation therapy and it's not exactly pleased

Andrew Pollack is probably the single most influential health writer in America. He has the bully pulpit the closest thing to a national platform. His reporting is excellent balanced and thorough. I had the privilege of speaking with him in April 2009 for a tamoxifen article though he did not quote me in the story. So it was somewhat provocative that Mr. Pollack seems not altogether happy about the trend towards maintenance therapy. Higher costs longer treatment.

Syndicate content